We are live on ! Find out more
LVACU

LAVA Medtech Acquisition Corp. Unit
LVACU

Delisted

LVACU was delisted on the 19th of April, 2023.

Back to rankings

39 hedge funds and large institutions have $66.5M invested in LAVA Medtech Acquisition Corp. Unit in 2021 Q4 according to their latest regulatory filings, with 39 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
39
Holders Change
+39
Holders Change %
–
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
39
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CCA
Castle Creek Arbitrage
Colorado
+$6.07M
2
SCM
Shaolin Capital Management
Florida
+$5.06M
3
GL
Governors Lane
New York
+$4.96M
4
PC
Periscope Capital
Ontario, Canada
+$4.07M
5
MP
Mangrove Partners
Connecticut
+$4.05M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
ECM
26
ExodusPoint Capital Management
New York
$524K +$506K +50,000 New
WC
27
Wealthspring Capital
New York
$523K +$526K +52,000 New
WA
28
Whitebox Advisors
Minnesota
$504K +$506K +50,000 New
SIA
29
Schechter Investment Advisors
Michigan
$483K +$486K +48,000 New
GCL
30
Glazer Capital LLC
New York
$323K +$325K +32,154 New
Calamos Advisors
31
Calamos Advisors
Illinois
$262K +$253K +25,000 New
LP
32
LMR Partners
United Kingdom
$252K +$253K +25,000 New
AllianceBernstein
33
AllianceBernstein
Tennessee
$248K +$250K +24,695 New
SMA
34
Sage Mountain Advisors
Georgia
$175K +$176K +17,400 New
CS
35
Clear Street
New York
$82K +$82.6K +8,166 New
AA
36
Ancora Advisors
Ohio
$34K +$34.5K +3,409 New
CCM
37
Condor Capital Management
New Jersey
$10K +$10.1K +1,000 New
UBS Group
38
UBS Group
Switzerland
$2K +$1.83K +181 New
TRCT
39
Tower Research Capital (TRC)
New York
$1K +$607 +60 New
1
2

LVACU Hedge Fund Activity: Q4 2021 in Review

39 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in LAVA Medtech Acquisition Corp. Unit (LVACU) for Q4 2021, worth a combined $66.5M.

Buyers outnumbered sellers: 39 funds opened new LVACU positions and 0 closed out — a net gain of 39 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Castle Creek Arbitrage, opening a new position worth an estimated $6.07M.

  • 39 institutional investors held LAVA Medtech Acquisition Corp. Unit (LVACU) as of Q4 2021, up from 0 in Q3 2021.
  • Funds reported $66.5M of LAVA Medtech Acquisition Corp. Unit stock for Q4 2021.
  • 39 funds opened new LAVA Medtech Acquisition Corp. Unit positions in Q4 2021 and 0 closed out, a net change of +39 holders.
  • The largest LAVA Medtech Acquisition Corp. Unit buyer in Q4 2021 was Castle Creek Arbitrage, an estimated $6.07M added.

Based on aggregated 13F filings for Q4 2021.